Commonwealth Equity Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Commonwealth Equity Services’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-134,037	Closed	-$118K	–	3907
2022 Q4	$118K	Sell	134,037 -11,192	-8%	-$14.8K	﹤0.01%	3382
2022 Q3	$228K	Sell	145,229 -20,488	-12%	-$46.5K	﹤0.01%	3062
2022 Q2	$333K	Buy	165,717 +9,415	+6%	+$16.3K	﹤0.01%	2744
2022 Q1	$364K	Buy	156,302 +72,340	+86%	+$226K	﹤0.01%	2797
2021 Q4	$390K	Sell	83,962 -5,300	-6%	-$32.9K	﹤0.01%	2739
2021 Q3	$681K	Buy	89,262 +3,380	+4%	+$28.7K	﹤0.01%	2237
2021 Q2	$832K	Buy	85,882 +11,445	+15%	+$91.1K	﹤0.01%	2057
2021 Q1	$615K	Sell	74,437 -11,394	-13%	-$120K	﹤0.01%	2156
2020 Q4	$585K	Buy	85,831 +20,478	+31%	+$164K	﹤0.01%	2038
2020 Q3	$728K	Sell	65,353 -34,413	-34%	-$315K	﹤0.01%	1694
2020 Q2	$626K	Buy	99,766 +76,246	+324%	+$292K	﹤0.01%	1728
2020 Q1	$43K	Buy	23,520 +13,100	+126%	+$37.7K	﹤0.01%	2698
2019 Q4	$35K	Sell	10,420 -6,526	-39%	-$15.6K	﹤0.01%	2830
2019 Q3	$36K	Buy	16,946 +6,763	+66%	+$15.8K	﹤0.01%	2764
2019 Q2	$27K	Hold	10,183	–	–	﹤0.01%	2728
2019 Q1	$48K	Sell	10,183 -29,414	-74%	-$77.2K	﹤0.01%	2665
2018 Q4	$95K	Buy	39,597 +14,916	+60%	+$48.7K	﹤0.01%	2499
2018 Q3	$108K	Sell	24,681 -112,556	-82%	-$624K	﹤0.01%	2630
2018 Q2	$988K	Buy	137,237 +9,146	+7%	+$62.2K	0.01%	1289
2018 Q1	$659K	Buy	+128,091	New	+$911K	﹤0.01%	1511

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

Commonwealth Equity Services's SRNE Position: Q1 2023 in Review

Commonwealth Equity Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 134,037 shares — an estimated $118K sold.

Commonwealth Equity Services first reported a position in SRNE in Q1 2018 and held it in 20 quarters. The position peaked at $988K in Q2 2018. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Commonwealth Equity Services reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Commonwealth Equity Services sold 134,037 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $118K.
Commonwealth Equity Services first reported a position in Sorrento Therapeutics, Inc. in Q1 2018 and held it in 20 quarters.
Commonwealth Equity Services's Sorrento Therapeutics, Inc. position peaked at $988K in Q2 2018.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.